Banque Pictet & Cie SA reduced its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 6.3% during the second quarter, HoldingsChannel reports. Banque Pictet & Cie SA’s holdings in Catalyst Pharmaceuticals were worth $470,000 as of its most recent filing with the SEC. Sound Income Strategies LLC bought a new stake in Catalyst Pharmaceuticals in the 1st quarter valued at about $64,000. Catalyst Pharmaceuticals Stock Up 2.0%Shares of Catalyst Pharmaceuticals stock opened at $19.52 on Friday. Receive News & Ratings for Catalyst Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalyst Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.